酸化ストレス,高密度リポタンパク質とHidradenitis Suppurativa:前向きな研究

Elisa Molinelli¹, Camilla Morresi², Maria Luisa Dragonetti¹

¹Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.

Antioxidants (Basel, Switzerland)

|August 28, 2025

まとめ

ハイドラデニティス・スプーラティブ (HS) の患者は,炎症が増加し,高密度リポタンパク質 (HDL) の抗酸化機能が低下する. これらのHDLの変化はHSの重症度と相関しており,疾患の病原性における役割を示唆している.

科学分野:

皮膚科
免疫学
心血管研究

背景:

ヒドラデニティス・スプーラティバ (HS) は,併発症と血管疾患に関連する慢性炎症性皮膚疾患である.
酸化ストレス,炎症,および高密度脂質タンパク質 (HDL) の機能の変化は,炎症性皮膚疾患に関連しています.
これらの要因とHSの病原性との特定の相互作用は,まだ完全に理解されていません.

研究の目的:

HS,酸化ストレス,炎症,およびHDL機能の関係を調査する.
炎症マーカー (SAA,MCP-1) とHDL関連抗酸化特性 (PON1活性,HDLリドックス状態) を分析する.
これらのマーカーとHSの重症性を関連付けます.

主な方法:

SAAとMCP-1の血清濃度は,HS患者の44人と健康な対照群の16人に測定された.
HDLに関連した抗酸化酵素であるパラオクソナーゼ-1 (PON1) の活性も評価された.
HDLのリドックス特性については,細胞フリー法を用いて評価した.

主要な成果:

HS患者は,対照群と比較して,MCP- 1とSAAの血清濃度が大幅に上昇した.
HDLの抗酸化能力の低下を示した.
これらのHDL機能障害は,HDLの血レベルとは無関係で,HSの重症度と相関していた.

結論:

炎症と酸化ストレスがHS患者のHDL機能障害に寄与する可能性があります.
機能不全のHDLは,HSの病原化と関連する合併症に役割を果たす可能性があります.
HDL機能障害を標的とした治療は,HSの潜在的な治療法です.

キーワード:

ヒドラデニティス・スプーラティバ高密度の脂質タンパク質酸化ストレスパラオクソナーゼ-1

さらに関連する動画

09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

06:19

Evaluation of Oxidative Stress in Biological Samples Using the Thiobarbituric Acid Reactive Substances Assay

Published on: May 12, 2020

29.6K

関連する概念動画

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

01:31

Lipid-derived Compounds in the Human Body

5.2K

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

5.2K

01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

関連する実験動画